Drug Patent Expirations for the Week of October 31, 2021

INBRIJA (levodopa) Acorda Patent: 7,556,798 Expiration: Nov 4, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Patent E…


New patent expiration for Acorda drug INBRIJA

Annual Drug Patent Expirations for INBRIJA Inbrija is a drug marketed by Acorda and is included in one NDA. It is available from one supplier. There are thirteen patents protecting…
The post New patent expiration for Acorda drug INBRIJA appeared first …


Biotechblog